Pharmacokinetic and dynamic genetic risk factors for QT prolongation with iloperidone therapy

James M. Stevenson; Jeffrey R. Bishop

doi:10.2217/pgs.13.123

Pharmacokinetic and dynamic genetic risk factors for QT prolongation with iloperidone therapy

Experimental and Clinical Pharmacology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1377-1378
Number of pages	2
Journal	Pharmacogenomics
Volume	14
Issue number	12
DOIs	https://doi.org/10.2217/pgs.13.123
State	Published - Sep 1 2013

Access

10.2217/pgs.13.123

OpenUrl availability

Full text

Cite this

@article{0315dc5a8eb846e5a2e4ffe2c96be81c,

title = "Pharmacokinetic and dynamic genetic risk factors for QT prolongation with iloperidone therapy",

author = "Stevenson, {James M.} and Bishop, {Jeffrey R.}",

year = "2013",

month = sep,

day = "1",

doi = "10.2217/pgs.13.123",

language = "English (US)",

volume = "14",

pages = "1377--1378",

journal = "Pharmacogenomics",

issn = "1462-2416",

publisher = "Future Medicine Ltd.",

number = "12",

}

TY - JOUR

T1 - Pharmacokinetic and dynamic genetic risk factors for QT prolongation with iloperidone therapy

AU - Stevenson, James M.

AU - Bishop, Jeffrey R.

PY - 2013/9/1

Y1 - 2013/9/1

UR - http://www.scopus.com/inward/record.url?scp=84883852304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883852304&partnerID=8YFLogxK

U2 - 10.2217/pgs.13.123

DO - 10.2217/pgs.13.123

M3 - Comment/debate

AN - SCOPUS:84883852304

SN - 1462-2416

VL - 14

SP - 1377

EP - 1378

JO - Pharmacogenomics

JF - Pharmacogenomics

IS - 12

ER -

Pharmacokinetic and dynamic genetic risk factors for QT prolongation with iloperidone therapy

Access

OpenUrl availability

Other files and links

Cite this